An alteration was observed by Olsson et al. in the ratio of estrogen receptor beta (ERβ) to CYP7B1 mRNA in the tumor regions, suggesting a potential disruption in estrogen signaling within prostate cancer cells [9]. This evidence concerns the gene ESR2 and prostate carcinoma.